Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: here I wait

part of the problem we are seeing (IMO) is the lack of any promotion of the company to the retail community.  we have never had any real promotion of this company.  we, the shareholders know very little, and we watch this thing daily.  so how does the world outside of PTSC know about us.  we are a penny stock so we are almost immediately off the radar of analysts and most retail investors have heard the warnings "to stay away from the pennies".  Our current PR pattern is a short paragraph stating a license was signed and that is about it...no financials to peak the interest or any follow up to promote the stock.

the fact that our volume is anemic (IMO) shows that the only real interest is from a handfull of traders, flippers, and possibly even the MM just moving shares back and forth.  will we see more interest in this stock?  I believe yes.  we did get a glimpse of the interest when we signed amd, intel, and hp....then i believe the curtain was pulled back a bit and retail saw a weak BOD, S&L issue, divies, and the sony deal and bailed.

we have come a long way since then and the BOD has been overhauled to a large extent, the warrant issue has been eliminated, S&L exposure has been greatly reduced, the markman hurdle was succesfully jumped.  i cannot believe that RG would have taken this CEO position and tied all of his compensation to a goal targeted options package if we were not in good shape.

be patient....if we conduct a true pr campaign with the release of great financial numbers we could be off to the races.  we need to PR this company.

glta teremoto

Share
New Message
Please login to post a reply